dobutamine has been researched along with Bone Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, MR; Bloomfield, SA; Swift, JM; Swift, SN | 1 |
1 other study(ies) available for dobutamine and Bone Neoplasms
| Article | Year |
|---|---|
Beta-1 adrenergic agonist treatment mitigates negative changes in cancellous bone microarchitecture and inhibits osteocyte apoptosis during disuse.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Apoptosis; Bone Density; Bone Neoplasms; Dobutamine; Femur; Humans; Osteocytes; Osteogenesis; Rats; Receptors, Adrenergic, beta-1; Tibia | 2014 |